Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 1st ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRFS | GRIFOLS SA | $6.76B | $9.83 | $10.30 | 4.78% | Hold | 1 | 8.76% | 128.42% | 17.25% | 4.74% | |||
| GSK | GSK PLC | $81.36B | $40.05 | N/A | N/A | N/A | N/A | 2.33% | 29.47% | 107.53% | 26.84% | |||
| LLY | ELI LILLY & CO | $723.76B | $764.71 | $908.50 | 18.80% | Strong Buy | 8 | 17.10% | 35.91% | 240.26% | 43.50% | |||
| BIIB | BIOGEN INC | $21.07B | $143.68 | $173.92 | 21.05% | Buy | 13 | -2.29% | 14.64% | 13.73% | 8.55% | |||
| SNY | SANOFI | $118.38B | $46.86 | $61.50 | 31.24% | Buy | 2 | 4.04% | 6.47% | 8.52% | 4.77% | |||
| AMRN | AMARIN CORP PLC | $308.79M | $14.93 | $12.00 | -19.62% | Strong Sell | 1 | -6.84% | N/A | -19.57% | -13.58% | |||
| NVS | NOVARTIS AG | $237.69B | $122.78 | $118.00 | -3.89% | Strong Sell | 1 | 1.69% | 13.66% | 45.00% | 18.10% | |||
| GILD | GILEAD SCIENCES INC | $137.56B | $110.86 | $123.70 | 11.58% | Buy | 10 | 3.04% | 22.01% | 64.73% | 22.85% | |||
| BMY | BRISTOL MYERS SQUIBB CO | $94.32B | $46.34 | $53.88 | 16.26% | Hold | 8 | -3.76% | 32.35% | 64.45% | 11.87% | |||
| AZN | ASTRAZENECA PLC | $240.44B | $77.56 | N/A | N/A | N/A | N/A | 5.37% | 29.55% | 20.35% | 8.09% | |||
| JNJ | JOHNSON & JOHNSON | $424.98B | $176.46 | $175.80 | -0.37% | Buy | 10 | 4.04% | 8.89% | 40.54% | 16.45% | |||
| PFE | PFIZER INC | $135.88B | $23.90 | $26.83 | 12.27% | Hold | 6 | -1.34% | 17.40% | 17.12% | 7.37% | |||
| ABBV | ABBVIE INC | $382.04B | $216.26 | $228.25 | 5.54% | Strong Buy | 12 | 6.82% | 96.78% | -16,578.43% | 22.12% | |||
| SCLX | SCILEX HOLDING CO | $156.92M | $22.56 | $630.00 | 2,692.55% | Strong Buy | 1 | 34.46% | N/A | N/A | -183.13% | |||
| MRK | MERCK & CO INC | $202.55B | $81.09 | $94.40 | 16.41% | Hold | 5 | 4.30% | 17.12% | 56.92% | 23.73% | |||
| AMGN | AMGEN INC | $147.02B | $273.09 | $307.50 | 12.60% | Hold | 10 | 2.09% | 21.50% | 162.13% | 13.70% | |||
| OGN | ORGANON & CO | $2.69B | $10.36 | $14.00 | 35.14% | Buy | 2 | 0.38% | 19.58% | 151.44% | 8.22% | |||
| NSRX | NASUS PHARMA LTD | N/A | $8.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| MIRA | MIRA PHARMACEUTICALS INC | $24.98M | $1.31 | N/A | N/A | N/A | N/A | N/A | N/A | -1,371.99% | -900.41% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.